<DOC>
	<DOCNO>NCT02986295</DOCNO>
	<brief_summary>Comparison safety long-term effect BioMimeTM stent Ultimaster® stent Xience® stent</brief_summary>
	<brief_title>Real World Drug-Eluting Stent Prospective , Open , Multi-site , Registry Korea : BioMimeTM Stent , Ultimaster® Stent vs. Xience® Stent By SMart Angioplastry Research Team ( SMARTDESK-MX )</brief_title>
	<detailed_description>A prospective , open , multicenter , observational study register compare Xience® group treat institution BioMime ™ , Ultimaster® group prospectively register June 2016 . The Xience® group already register previous study ( SMARTDESK-BX ) , BioMimeTM Ultimaster® need register . Follow-up conduct December 2019 , e-CRF complete April 2020 .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>1 . 19 year old old 2 . Clinical evidence coronary artery disease include asymptomatic ischemia , stable angina pectoris , acute coronary syndrome ( unstable angina , nonST segment elevation myocardial infarction , ST segment elevation myocardial infarction ) . 3 . Vessel diameter 2.25 ~ 3.5mm , stenosis 50 % ( However , number blood vessel , number lesion , lesion length limit ) 4 . Voluntary write consent participate trial 1 . Within 24 hour percutaneous coronary intervention , hemodynamic instability cardiogenic shock 2 . Life expectancy within 2 year</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>BioMime , Ultimaster , Ischemic heart disease , DES</keyword>
</DOC>